SAMN31516290
External Id
HOSPITAL CLINIC OF BARCELONA-ISGLOBAL
INSDC center name
2022-10-29T00:00:00Z
INSDC first public
2022-10-29T01:01:06.330Z
INSDC last update
SRS15579423
INSDC secondary accession
live
INSDC status
SARS-CoV-2: clinical or host-associated
NCBI submission model
SARS-CoV-2.cl.1.0
NCBI submission package
SRS15579423
SRA accession
Remdesivir 5 days
antiviral_treatment_agent
Hospital Clinic of Barcelona
collected_by
2021-02/2021-11
collection_date
Spain: Barcelona
geo_loc_name
Homo sapiens
host
COVID-19
host_disease
clinical isolates from patients pre and post remdesivir treatment from 1 to 28 recevied 5 days of remdesivir and from 29 to 45 received prolonged treatments. The reamaining sequences were not available to be published.
isolate
nasopharingeal or throat swab
isolation_source
Severe acute respiratory syndrome coronavirus 2
http://purl.obolibrary.org/obo/NCBITaxon_2697049
organism
SARS-CoV-2: clinical or host-associated sample from Severe acute respiratory syndrome coronavirus 2
title